Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
INTELLIPHARMACEUT
(NQ:
IPCI
)
2.790
USD
UNCHANGED
Official Closing Price
/ Updated:
8:10 PM EDT, Jul 24, 2014
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
74,377
Open
2.720
Bid (Size)
2.520 (700)
Ask (Size)
3.990 (300)
Prev. Close
2.790
Today's Range
2.700 - 2.840
52wk Range
1.630 - 6.460
Shares Outstanding
23,329,111
Dividend Yield
N/A
Performance
YTD
-24.59%
-24.59%
1 Month
-23.98%
-23.98%
3 Month
-26.19%
-26.19%
6 Month
-29.72%
-29.72%
1 Year
+39.50%
+39.50%
Top News
More News
Intellipharmaceutics Announces Second Quarter 2014 Results
July 07, 2014
from
GlobeNewswire News Releases
Intellipharmaceutics Files Preliminary Base Shelf Prospectus and Shelf Registration Statement
May 20, 2014
from
GlobeNewswire News Releases
More News
Read More
Pharma Stocks Technical Briefing -- Research on Forest Laboratories, Valeant Pharma, IntelliPharmaCeutics Intl., and Acura Pharma
May 08, 2014
from
PR Newswire
Intellipharmaceutics Announces First Quarter 2014 Results
April 14, 2014
from
GlobeNewswire News Releases
Reviewing the Top Health Care Equities -- Research on IntelliPharmaCeutics, Delcath Systems, Valeant Pharma and Alkermes
March 21, 2014
from
PR Newswire
Intellipharmaceutics -- Amended Form of Proxy for Shareholders Meeting to be Held on March 27, 2014
March 19, 2014
from
GlobeNewswire News Releases
Correction - Mackie Research Capital Initiates Coverage on Intellipharmaceutics Intl (NASDAQ:IPCI) (TSX:I) with a Speculative Buy Recommendation - Video Research Alert on InvestmentPitch.com
March 17, 2014
from
GlobeNewswire News Releases
Jennings Capital Initiates Coverage on Intellipharmaceutics Intl with a Speculative Buy Recommendation - Video Research Alert on InvestmentPitch.com
March 14, 2014
from
Newsfile Corp News Releases
Jennings Capital Initiates Coverage on Intellipharmaceutics Intl (NASDAQ:IPCI) (TSX:I) with a Speculative Buy Recommendation - Video Research Alert on InvestmentPitch.com
March 14, 2014
from
GlobeNewswire News Releases
Approvals, Clinical Trial Results, Stock Summaries, Data Publication and Conference Participation - Analyst Notes on Northwest, La Jolla Pharma, Merrimack Pharma, Rosetta, and IntelliPharmaCeutics
March 13, 2014
from
PR Newswire
Intellipharmaceutics to Present at Two Upcoming Investor Conferences
March 04, 2014
from
GlobeNewswire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates
Bots go here